CAI – caris life sciences, inc. (US:NASDAQ)
Stock Stats
News
Caris Life Sciences: Stronger Fundamentals, Same Conclusion [Seeking Alpha]
Caris Life Sciences (NASDAQ:CAI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $28.00 to $30.00. They now have a "hold" rating on the stock.
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
Caris Life Sciences (NASDAQ:CAI) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need [Yahoo! Finance]
Form 4 Caris Life Sciences, For: Dec 11 Filed by: Power Luke Thomas
Form 4 Caris Life Sciences, For: Dec 10 Filed by: Brille Brian J
Form 144 Caris Life Sciences, Filed by: Power Luke Thomas
Form 4 Caris Life Sciences, For: Nov 07 Filed by: Denton John Russel
Form 4 Caris Life Sciences, For: Nov 07 Filed by: Spetzler David Baxley
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.